Mouse models showed that NLRP3 inhibition could prevent motor deficits and cerebellar degeneration induced by chronic Meth administration, implying the potential therapeutic roles of NLRP3 inflammasome on neurological symptoms in chronic Meth users [63]. This evidence concerns the gene NLRP3 and cerebellar degeneration.